Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome

Introduction/Objective. Radiofrequency ablation (RFA) is a minimally invasive treatment modality for primary and metastatic liver tumors. It can be performed percutaneously or as a laparoscopic or open surgical procedure under ultrasound or computerized tomography guidance. The objective of the stud...

Full description

Bibliographic Details
Main Authors: Mašulović Dragan, Galun Danijel, Stević Ruža, Filipović Aleksandar, Bogdanović Aleksandar, Milićević Miroslav N.
Format: Article
Language:English
Published: Serbian Medical Society 2017-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2017/0370-81791700096M.pdf
_version_ 1818461743758704640
author Mašulović Dragan
Galun Danijel
Stević Ruža
Filipović Aleksandar
Bogdanović Aleksandar
Milićević Miroslav N.
author_facet Mašulović Dragan
Galun Danijel
Stević Ruža
Filipović Aleksandar
Bogdanović Aleksandar
Milićević Miroslav N.
author_sort Mašulović Dragan
collection DOAJ
description Introduction/Objective. Radiofrequency ablation (RFA) is a minimally invasive treatment modality for primary and metastatic liver tumors. It can be performed percutaneously or as a laparoscopic or open surgical procedure under ultrasound or computerized tomography guidance. The objective of the study was to evaluate the clinical outcome of the initial 16 patients with hepatocellular carcinoma (HCC) managed by percutaneous RFA at a tertiary institution and to assess the efficacy of this procedure in the management of selected patients with HCC. Method. From June 2011 until December 2013, 16 patients with early-stage HCC were managed by percutaneous radiofrequency ablation at the Clinic for Digestive Surgery, Clinical Center of Serbia, Belgrade. All the patients were treated by the same team composed of an interventional radiologist and a liver surgeon. We analyzed the clinical outcome and the biologic effect of this treatment by comparing the pre- and post-treatment levels of alpha-fetoprotein (AFP). Results. Post-treatment values of liver transaminase levels returned to the pre-treatment values from Day 3. Post-treatment hospital stay was two days. Post-procedural complications included mild pain in all patients, skin necrosis at the site of the electrode puncture in five patients, and transient hepatic decompensation in one patient. In all the patients the AFP level correlated with the findings of liver imaging (ultrasound and/or magnetic resonance imaging with liver-specific contrast agent) indicating viability of the treated tumor. Conclusion. RFA is a feasible and effective procedure providing favorable clinical outcome in patients with early-stage HCC.
first_indexed 2024-12-14T23:51:00Z
format Article
id doaj.art-d3b9050728f34a27b9683b3218c30b81
institution Directory Open Access Journal
issn 0370-8179
2406-0895
language English
last_indexed 2024-12-14T23:51:00Z
publishDate 2017-01-01
publisher Serbian Medical Society
record_format Article
series Srpski Arhiv za Celokupno Lekarstvo
spelling doaj.art-d3b9050728f34a27b9683b3218c30b812022-12-21T22:43:15ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792406-08952017-01-011459-1047548010.2298/SARH160617096M0370-81791700096MRadiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcomeMašulović Dragan0Galun Danijel1Stević Ruža2Filipović Aleksandar3Bogdanović Aleksandar4Milićević Miroslav N.5Medical School, Belgrade + Clinical center of Serbia, Center for Radiology and Magnetic Resonance, BelgradeMedical School, Belgrade + Clinical Center of Serbia, Clinic for Digestive Surgery, BelgradeMedical School, Belgrade + Clinical center of Serbia, Center for Radiology and Magnetic Resonance, BelgradeClinical center of Serbia, Center for Radiology and Magnetic Resonance, BelgradeClinical Center of Serbia, Clinic for Digestive Surgery, BelgradeMedical School, Belgrade + Clinical Center of Serbia, Clinic for Digestive Surgery, BelgradeIntroduction/Objective. Radiofrequency ablation (RFA) is a minimally invasive treatment modality for primary and metastatic liver tumors. It can be performed percutaneously or as a laparoscopic or open surgical procedure under ultrasound or computerized tomography guidance. The objective of the study was to evaluate the clinical outcome of the initial 16 patients with hepatocellular carcinoma (HCC) managed by percutaneous RFA at a tertiary institution and to assess the efficacy of this procedure in the management of selected patients with HCC. Method. From June 2011 until December 2013, 16 patients with early-stage HCC were managed by percutaneous radiofrequency ablation at the Clinic for Digestive Surgery, Clinical Center of Serbia, Belgrade. All the patients were treated by the same team composed of an interventional radiologist and a liver surgeon. We analyzed the clinical outcome and the biologic effect of this treatment by comparing the pre- and post-treatment levels of alpha-fetoprotein (AFP). Results. Post-treatment values of liver transaminase levels returned to the pre-treatment values from Day 3. Post-treatment hospital stay was two days. Post-procedural complications included mild pain in all patients, skin necrosis at the site of the electrode puncture in five patients, and transient hepatic decompensation in one patient. In all the patients the AFP level correlated with the findings of liver imaging (ultrasound and/or magnetic resonance imaging with liver-specific contrast agent) indicating viability of the treated tumor. Conclusion. RFA is a feasible and effective procedure providing favorable clinical outcome in patients with early-stage HCC.http://www.doiserbia.nb.rs/img/doi/0370-8179/2017/0370-81791700096M.pdfradiofrequency ablationhepatocellular carcinomabiologic effectpercutaneous approach
spellingShingle Mašulović Dragan
Galun Danijel
Stević Ruža
Filipović Aleksandar
Bogdanović Aleksandar
Milićević Miroslav N.
Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
Srpski Arhiv za Celokupno Lekarstvo
radiofrequency ablation
hepatocellular carcinoma
biologic effect
percutaneous approach
title Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
title_full Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
title_fullStr Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
title_full_unstemmed Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
title_short Radiofrequency ablation for hepatocellular carcinoma - analysis of the clinical outcome
title_sort radiofrequency ablation for hepatocellular carcinoma analysis of the clinical outcome
topic radiofrequency ablation
hepatocellular carcinoma
biologic effect
percutaneous approach
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2017/0370-81791700096M.pdf
work_keys_str_mv AT masulovicdragan radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome
AT galundanijel radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome
AT stevicruza radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome
AT filipovicaleksandar radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome
AT bogdanovicaleksandar radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome
AT milicevicmiroslavn radiofrequencyablationforhepatocellularcarcinomaanalysisoftheclinicaloutcome